Photodynamical therapy (PDT), as an emerging treatment modality, which takes advantage of reactive oxygen species (ROS) initiated by light illumination to ablate tumor, has suffered from the limited treatment depth,...

Exploiting two-dimensional nanomaterials as photo-based theranostic agent has witnessed great promise in highly effective ablation of deep-tissue buried tumors. However, it’s still limited by their poor absorption in the second...

No abstract

Photodynamic therapy (PDT) with organic photosensitizers generally goes through the oxygen‐dependent process, generating singlet oxygen and/or superoxide anion. However, the generation of reactive oxygen species is often suppressed as a result of hypoxia, one of the common features in tumors, therefore limiting the effectiveness of the tumor treatments. Consequently, it is urgent and significant to develop an oxygen‐independent hydroxyl radical photogenerator and unveil the mechanism. In this work, a hydroxyl radical (·OH) photogenerator originating from the electron transfer process is engineered. Detailed mechanism studies reveal that the optimized photosensitizer, WS2D, which contains a bithiophene unit, could both promote charge carrier generation and accelerate reaction efficiency, resulting in the efficient production of ·OH. In addition, WS2D nanoparticles are constructed to improve the polydispersity and stability in aqueous solution, which exhibit excellent biocompatibility and mitochondrial targeting. Bearing the above advantages, WS2D is employed in phototheranostics, which could release ·OH effectively and damage mitochondria precisely, achieving high PDT efficiency in vitro and in vivo. Overall, this work successfully provides valuable insights into the structural design of a hydroxyl radicals (·OH) photogenerator with great practical perspectives.